Mohamed Elgawish

Dr. Mohamed Elgawish

Institute for Basic Sciences, Korea University
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2022 in Advanced Science
Verified
Journal Article
Open access
PDF file
JKJiwoong Kwon
Jiwoong Kwon
Mohamed ElgawishMohamed Elgawish
Mohamed Elgawish
SSSang‐Hee Shim
Sang‐Hee Shim
Photobleaching is the permanent loss of fluorescence after extended exposure to light and is a major limiting factor in super‐resolution microscopy (SRM) that restricts spatiotemporal resolution and observation time. Strategies for preventing or overcoming photobleaching in SRM are reviewed developing new probes and chemical environments. Photostabilization strategies are introduced first, which are borrowed from conventional fluorescence microscopy, that are employed in SRM. SRM‐specific strategies are then highlighted that exploit the on–off transitions of fluorescence, which is the key mechanism for achieving super‐resolution, which are becoming new routes to address photobleaching in SRM. Off states can serve as a shelter from excitation by light or an exit to release a damaged probe and replace it with a fresh one. Such efforts in overcoming the photobleaching limits are anticipated to enhance resolution to molecular scales and to extend the observation time to physiological lifespans.

14 August 2020 in Plants
Verified
Journal Article
Open access
PDF file
Sameh S. ElhadySameh S. Elhady
Sameh S. Elhady
Enas EltamanyEnas Eltamany
Enas Eltamany
ASAmera E. Shaaban
Amera E. Shaaban
ABAlaa A. Bagalagel
Alaa A. Bagalagel
YMYosra Muhammad
Yosra Muhammad
SASafwat Ahmed
Safwat Ahmed
Phytochemical study of Chiliadenus montanus aerial parts afforded six compounds; Intermedeol (1), 5α-hydroperoxy-β-eudesmol (2), 5,7-dihydroxy-3,3’,4’-trimethoxyflavone (3), 5,7,4’-trihydroxy-3,6,3’-trimethoxyflavone (jaceidin) (4), eudesm-11,13-ene-1β,4β,7α-triol (5) and 1β,4β,7β,11-tetrahydroxyeudesmane (6). These compounds were identified based on their NMR spectral data. The isolated compounds were tested for their cytotoxicity against liver cancer cell line (HepG2) and breast cancer cell line (MCF-7). Jaceidin flavonoid (4) exhibited the highest cytotoxic effect in vitro. Therefore, both of jaceidin and C. montanus extract were evaluated for their in vivo anti-tumor activity against Ehrlich’s ascites carcinoma (EAC). Compared to control group, jaceidin and C. montanus extract decreased the tumor weight, improved the histological picture of tumor cells, lowered the levels of VEGF and ameliorate the oxidative stress. Molecular docking and in silico studies suggested that jaceidin was a selective inhibitor of VEGF-mediated angiogenesis with excellent membrane permeability and oral bioavailability.

1 January 2011 in Saudi Pharmaceutical Journal
Verified
Journal Article
Open access
Mohamed ElgawishMohamed Elgawish
Mohamed Elgawish
SMSamia M. Mostafa
Samia M. Mostafa
AEAbdalla A. Elshanawane
Abdalla A. Elshanawane
A simple, sensitive and rapid chromatographic method was developed and validated for the simultaneous quantification of atenolol and chlorthalidone in human plasma using hydrochlorothiazide as internal standard (IS). The method utilized proteins precipitation with acetonitril as the only sample preparation involved prior to reverse phase-HPLC. The analytes were chromatographed on Shim-pack cyanopropyl column with isocratic elution with 10 mM KH2PO4 (pH 6.0) - methanol (70:30, v/v) at ambient temperature with flow rate of 1 mL min(-1) and UV detection at 225 nm. The chromatographic run time was less than 10 min for the mixture. The calibration curves were linear over the range of 0.1-10 μg mL(-1). The method was validated in terms of accuracy, precision, absolute recovery, freeze-thaw stability, bench-top stability and re-injection reproducibility. The within- and between-day accuracy and precision were found to be within acceptable limits <15%. The analytes were stable after three freeze-thaw cycles (deviation <15%). The proposed method was specific for the simultaneous determination of atenolol and chlorthalidone in human plasma where there was no interference from endogenous biological substances.

1 May 2019 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
HDHosam Eldin Dahshan
Hosam Eldin Dahshan
MHMohamed A. Helal
Mohamed A. Helal
SMSamia M. Mostafa
Samia M. Mostafa
Mohamed ElgawishMohamed Elgawish
Mohamed Elgawish

1 May 2019 in Bioorganic Chemistry
Verified
Journal Article
Closed access
NGNagat Ghareb
Nagat Ghareb
NENorhan Mohamed El-Sayed
Norhan Mohamed El-Sayed
RAReda F. A. Abdelhameed
Reda F. A. Abdelhameed
KYKoji Yamada
Koji Yamada
Mohamed ElgawishMohamed Elgawish
Mohamed Elgawish

24 December 2020 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
REranza elrayess
ranza elrayess
YAYasmine M. Abdel Aziz
Yasmine M. Abdel Aziz
Mohamed ElgawishMohamed Elgawish
Mohamed Elgawish
MEMarwa Elewa
Marwa Elewa
AYAsmaa yassen
Asmaa yassen
MSMohamed M. Said
Mohamed M. Said
Dual targeting of epidermal growth factor receptor (EGFR) and human EGFR-related receptor 2 (HER2) is a proven approach for the treatment of lung cancer. With the aim of discovering effective dual EGFR/HER2 inhibitors targeting non-small cell lung cancer cell line H1299, three series of thieno[2,3-d][1,2,3]triazine and acetamide derivatives were designed, synthesized, and biologically evaluated. The synthesized compounds displayed IC50 values ranging from 12 to 54 nM against H1299, which were superior to that of gefitinib (2) at 40 µM. Of the synthesized compounds, 2-(1H-pyrazolo[3,4-b]pyridin-3-ylamino)-N-(3-cyano4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)acetamide (21a) achieved the highest in vitro cytotoxic activity against H1299, with an IC50 value of 12.5 nM in situ, and 0.47 and 0.14 nM against EGFR and HER2, respectively, values comparable to the IC50 of the approved drug imatinib (1). Our synthesized compounds were promising, demonstrating high selectivity and affinity for EGFR/HER2, especially the hinge region forming a hydrophobic pocket, which was mediated by hydrogen bonding as well as hydrophobic and electrostatic interactions, as indicated by molecular modeling. Moreover, the designed compounds showed good affinity for T790M EGFR, one of the main mutants resulting in acquired drug resistance. Furthermore, both pharmacokinetic and physicochemical properties of the designed compounds were within the appropriate range for human usage as predicted by the in Silico ADME study. The designed compound (21a) might serve as an encouraging lead compound for the discovery of promising anti-lung cancer agents targeting EGFR/HER2.